Catalyst Clinical Research provides customizable consulting solutions to biopharmaceutical and biotechnology industries through Catalyst Oncology Consulting, a part of Catalyst Oncology, our full-service, specialty clinical research organization (CRO). Catalyst Oncology Consulting focuses on the development of innovative cancer treatments. Our consultancy services are designed to be delivered as a standalone service or seamlessly paired with a full-service oncology clinical trial offering. Catalyst Oncology Consulting develops and delivers optimized drug development plans to support clients to deliver their best assets, including immuno-oncology, to investors and patients. We provide customers with teams experienced across all functions, knowledgeable in complex drug classes and study designs, and with data-centric methodologies that help bring next-generation therapies to cancer patients. Visit Catalyst Oncology Consulting or follow Catalyst Oncology on LinkedIn.